Skip to main content
SpringerLink
Log in

Cardiovascular Disease Risk Prediction - Integration into Clinical Practice

  • Secondary Prevention and Intervention (J Foody, Section Editor)
  • Published:
Current Cardiovascular Risk Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig 1
Fig 2
Fig. 3

References

Papers of particular interest, published recently, have been highlighted as: • Of importance, •• Of major importance

  1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics—2013 update a report from the American Heart Association. Circulation. 2013;127(1):e6–e245.

    Article  PubMed  Google Scholar 

  2. Karmali KN, Lloyd-Jones DM. Adding a life-course perspective to cardiovascular-risk communication. Nature Rev Cardiol. 2013;10(2):111–5.

    Article  Google Scholar 

  3. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121(1):293–8.

    Article  PubMed  CAS  Google Scholar 

  4. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ. 2008;336(7659):1475–82.

    Article  PubMed  Google Scholar 

  5. Conroy R, Pyörälä K, Fitzgerald A, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987–1003.

    Article  PubMed  CAS  Google Scholar 

  6. Pignone M, Phillips CJ, Elasy TA, Fernandez A. Physicians' ability to predict the risk of coronary heart disease. BMC Health Serv Res. 2003;3(1):13.

    Article  PubMed  Google Scholar 

  7. van der Weijden T, Bos LB, Koelewijn-van Loon MS. Primary care patients' recognition of their own risk for cardiovascular disease: implications for risk communication in practice. Curr Opin Cardiol. 2008;23(5):471–6.

    Article  PubMed  Google Scholar 

  8. Webster R, Heeley E. Perceptions of risk: understanding cardiovascular disease. Risk Manage Healthcare Policy. 2010;3:49.

    Article  Google Scholar 

  9. Cleeman J, Grundy S, Becker D, Clark L. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP III). JAMA. 2001;285(19):2486–97.

    Article  Google Scholar 

  10. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult–2009 recommendations. Can J Cardiol. 2009;25(10):567–79.

    Article  PubMed  CAS  Google Scholar 

  11. Jackson R. Updated New Zealand cardiovascular disease risk-benefit prediction guide. BMJ. 2000;320(7236):709–10.

    Article  PubMed  CAS  Google Scholar 

  12. Perk J, De Backer G, Gohlke H, Graham I, Reiner Ž, Verschuren M, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2012;33(13):1635–701.

    Article  PubMed  CAS  Google Scholar 

  13. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–47.

    Article  PubMed  CAS  Google Scholar 

  14. D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care the Framingham Heart Study. Circulation. 2008;117(6):743–53.

    Article  PubMed  Google Scholar 

  15. Pencina MJ, D'Agostino Sr RB, Larson MG, Massaro JM, Vasan RS. Predicting the 30-year risk of cardiovascular disease The Framingham Heart Study. Circulation. 2009;119(24):3078–84.

    Article  PubMed  Google Scholar 

  16. Lloyd-Jones DM, Leip EP, Larson MG, D’Agostino RB, Beiser A, Wilson PW, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006;113(6):791–8.

    Article  PubMed  Google Scholar 

  17. Woodward M, Brindle P, Tunstall-Pedoe H. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart. 2007;93(2):172–6.

    Article  PubMed  Google Scholar 

  18. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ: Br Med J. 2007;335(7611):136.

    Article  Google Scholar 

  19. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation. 2002;105(3):310–5.

    Article  PubMed  Google Scholar 

  20. Mureddu GF, Brandimarte F, Faggiano P, Rigo F, Nixdorff U. Between risk charts and imaging: how should we stratify cardiovascular risk in clinical practice? Eur Heart J Cardiovasc Imaging. 2013.

  21. Michos ED, Blumenthal RS. How accurate are 3 risk prediction models in US women? Circulation. 2012;125(14):1723–6.

    Article  PubMed  Google Scholar 

  22. •• Allan GM, Nouri F, Korownyk C, Kolber MR, Vandermeer B, McCormack J. Agreement among cardiovascular disease risk calculators. Circulation. 2013;127(19):1948–56. The study examined agreement of risk classification of 25 different cardiovascular risk calculators for 128 hypothetical patients. The study showed that pairs of calculators will assign a different category to the same patient approximately one third of the time.

    Article  PubMed  Google Scholar 

  23. Jackson R, Kerr A, Wells S. Vascular risk calculators essential but flawed clinical tools? Circulation. 2013;127(19):1929–31.

    Article  PubMed  Google Scholar 

  24. Lackland DT, Elkind MS, D'Agostino R, Dhamoon MS, Goff DC, Higashida RT, et al. Inclusion of stroke in cardiovascular risk prediction instruments a statement for healthcare professionals from the American heart association/American stroke association. Stroke. 2012;43(7):1998–2027.

    Article  PubMed  Google Scholar 

  25. Berry JD, Lloyd-Jones DM, Garside DB, Greenland P. Framingham risk score and prediction of coronary heart disease death in young men. Am Heart J. 2007;154(1):80–6.

    Article  PubMed  Google Scholar 

  26. Cavanaugh-Hussey MW, Berry JD, Lloyd-Jones DM. Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool. Preventive medicine. 2008;47(6):619–23.

    Article  PubMed  Google Scholar 

  27. Marma AK, Berry JD, Ning H, Persell SD, Lloyd-Jones DM. Distribution of 10-Year and Lifetime Predicted Risks for Cardiovascular Disease in US Adults Findings From the National Health and Nutrition Examination Survey 2003 to 2006. Circ Cardiovasc Qual Outcomes. 2010;3(1):8–14.

    Article  PubMed  Google Scholar 

  28. Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet. 1999;353(9147):89.

    Article  PubMed  CAS  Google Scholar 

  29. Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, et al. Lifetime risks of cardiovascular disease. New Engl J Med. 2012;366(4):321–9.

    Article  PubMed  CAS  Google Scholar 

  30. •• Wilkins JT, Ning H, Berry J, Zhao L, Dyer AR, Lloyd-Jones DM. Lifetime Risk and Years Lived Free of Total Cardiovascular DiseaseLifetime Risk and Years Lived Free of Total CVD. JAMA. 2012;308(17):1795–801. This study estimated life time risk for global CVD using the aggregate risk factor burden. It also showed that although the lifetime risk for total CVD in adults with optimal RFs at middle age was high and exceeded 30% to 40%, their CVD developed 8 to 14 years later compared to those with at least 2 major RFs.

    Article  PubMed  CAS  Google Scholar 

  31. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. New Engl J Med. 2008;358(13):1336–45.

    Article  PubMed  CAS  Google Scholar 

  32. Erbel R, Möhlenkamp S, Moebus S, Schmermund A, Lehmann N, Stang A, et al. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosisthe heinz nixdorf recall study. J Am Coll Cardiol. 2010;56(17):1397–406.

    Article  PubMed  Google Scholar 

  33. • Nasir K, Rubin J, Blaha MJ, Shaw LJ, Blankstein R, Rivera JJ, et al. Interplay of Coronary Artery Calcification and Traditional Risk Factors for the Prediction of All-Cause Mortality in Asymptomatic IndividualsClinical Perspective. Circ CardiovascImaging. 2012;5(4):467–73. This study showed that individuals without risk factors (RFs) but elevated CAC have substantially higher event rates than those who have multiple RFs but no CAC.

    Article  Google Scholar 

  34. Blaha M, Budoff MJ, Shaw LJ, Khosa F, Rumberger JA, Berman D, et al. Absence of coronary artery calcification and all-cause mortality. JACC: Cardiovasc Imaging. 2009;2(6):692–700.

    Article  Google Scholar 

  35. Budoff MJ, McClelland RL, Nasir K, Greenland P, Kronmal RA, Kondos GT, et al. Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2009;158(4):554.

    Article  PubMed  Google Scholar 

  36. Lakoski SG, Greenland P, Wong ND, Schreiner PJ, Herrington DM, Kronmal RA, et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as" low risk" based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA). Arch Int Med. 2007;167(22):2437.

    Article  Google Scholar 

  37. Raggi P, Gongora MC, Gopal A, Callister TQ, Budoff M, Shaw LJ. Coronary artery calcium to predict all-cause mortality in elderly men and women. J Am Coll Cardiol. 2008;52(1):17–23.

    Article  PubMed  Google Scholar 

  38. Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol. 2004;43(9):1663–9.

    Article  PubMed  CAS  Google Scholar 

  39. Greenland P, Alpert JS. ACCF/AHA practice guideline. Circulation. 2010;122:2748–64.

    Article  PubMed  Google Scholar 

  40. Sheridan SL, Viera AJ, Krantz MJ, Ice CL, Steinman LE, Peters KE, et al. The effect of giving global coronary risk information to adults: a systematic review. Arch Int Med. 2010;170(3):230.

    Article  Google Scholar 

  41. Hobbs F, Jukema J, Da Silva P, McCormack T, Catapano A. Barriers to cardiovascular disease risk scoring and primary prevention in Europe. QJM. 2010;103(10):727–39.

    Article  PubMed  CAS  Google Scholar 

  42. Liew SM, Doust J, Glasziou P. Cardiovascular risk scores do not account for the effect of treatment: a review. Heart. 2011;97(9):689–97.

    Article  PubMed  CAS  Google Scholar 

  43. Persell SD, Zei C, Cameron KA, Zielinski M, Lloyd-Jones DM. Potential use of 10-year and lifetime coronary risk information for preventive cardiology prescribing decisions: a primary care physician survey. Arch Int Med. 2010;170(5):470.

    Article  Google Scholar 

  44. Soureti A, Hurling R, Murray P, van Mechelen W, Cobain M. Evaluation of a cardiovascular disease risk assessment tool for the promotion of healthier lifestyles. Eur J Cardiovasc Prev Rehabil. 2010;17(5):519–23.

    Article  PubMed  Google Scholar 

  45. Madanieh R, Hasan R, Anusionwu O, Blumenthal R, Blaha M. Cardiovascular disease prevention: matching evidence-based algorithms with individualized care. Clin Pharmacol Ther. 2013 Apr;93(4):321–3. doi:10.1038/clpt.2013.3.

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Thura T. Abd, Michael J. Blaha, Roger S. Blumenthal, and Parag H. Joshi declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD, USA

    Thura T. Abd, Michael J. Blaha, Roger S. Blumenthal & Parag H. Joshi

Authors
  1. Thura T. Abd
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael J. Blaha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roger S. Blumenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Parag H. Joshi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Thura T. Abd or Roger S. Blumenthal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abd, T.T., Blaha, M.J., Blumenthal, R.S. et al. Cardiovascular Disease Risk Prediction - Integration into Clinical Practice. Curr Cardiovasc Risk Rep 7, 346–353 (2013). https://doi.org/10.1007/s12170-013-0332-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12170-013-0332-y

Keywords

Search

Navigation